Annual report 2023

Compensation of the Board of Directors for 2023

The following table discloses the compensation paid to the members of the Board of Directors for financial year 2023 while performing services for medmix:

 

 

2023

thousands of CHF

 

Cash fees

 

Restricted share unit (RSU) plan 3)

 

Social security contributions 5)

 

Total

Rob ten Hoedt, Chairman 2)

 

131

 

150

 

21

 

302

Barbara Angehrn 2)

 

70

 

65

 

11

 

146

Daniel O. Flammer 2)

 

70

 

65

 

11

 

146

David Metzger 2)

 

68

 

65

 

11

 

144

Greg Poux-Guillaume 1)

 

95

 

60

 

12

 

167

Marco Musetti 1)

 

78

 

73

 

12

 

163

René Willi 2)

 

70

 

65

 

11

 

146

Board of Directors

 

582

 

543

 

89

 

1’214

The following table discloses the compensation paid to the members of the Board of Directors for financial year 2022 while performing services for medmix:

 

 

2022

thousands of CHF

 

Cash fees

 

Restricted share unit (RSU) plan 4)

 

Social security contributions 5)

 

Total

Greg Poux-Guillaume, Chairman 1)

 

150

 

150

 

23

 

323

Barbara Angehrn 2)

 

49

 

65

 

9

 

123

Daniel O. Flammer 2)

 

49

 

65

 

9

 

123

David Metzger 2)

 

45

 

60

 

8

 

113

Marco Musetti 1)

 

74

 

73

 

12

 

159

René Willi 2)

 

49

 

65

 

9

 

123

Rob ten Hoedt 2)

 

54

 

73

 

10

 

137

Jill Lee 6)

 

19

 

0

 

2

 

21

Board of Directors

 

489

 

551

 

82

 

1’122

1) Member of the Board of Directors since September 20, 2021.

2) Member of the Board of Directors since April 12, 2022.

3) RSU awards granted in 2023. Grant price was CHF 21.57 (three-month volume weighted average share price) and fair value was CHF 20.65.

4) RSU awards granted in 2022. Grant price was CHF 32.74 (three-month volume weighted average share price) and fair value was CHF 32.08.

5) The amount includes mandatory social security contributions on the cash fees and estimated contributions on the RSU (based on their fair value at grant) paid by the company on behalf of the Board members.

6) Member of the Board of Directors from September 20, 2021 to April 12, 2022.

As of December 31, 2023 and 2022, respectively, there were no outstanding loans or credits granted to the members of the Board of Directors, former members of the Board of Directors or related parties. In 2023 and 2022, respectively, no compensation, loans or credits were granted to former members of the Board of Directors or related parties.

Reconciliation between the reported board compensation and the amount approved by the shareholders at AGM

At the AGM 2023, shareholders approved a maximum aggregate compensation amount of CHF 1'500'000 for the Board of Directors for the period of office from the 2023 AGM until the end of the 2024 AGM. The table below shows the reconciliation between the compensation that was/will be paid out for the periods of office and the maximum aggregate compensation amounts approved by the shareholders.

thousands of CHF

 

Compensation earned during financial year as reported (A)

 

Less compensation earned from Jan to AGM of financial year (B)

 

Plus compensation accrued from Jan to AGM of year following financial year (C)

 

Total compensation earned for the period from AGM to AGM of medmix (A-B+C)

 

Amount approved by shareholders at respective AGM

 

Ratio between compensation earned for the period from AGM to AGM versus amount approved by shareholders

2023 AGM - 2024 AGM

 

2023

 

January 01, 2023 to 2023 AGM medmix

 

January 01, 2024 to 2024 AGM medmix

 

2023 AGM to 2024 AGM

 

2023 AGM

 

2023 AGM

Board of Directors Total

 

1’214

 

202

 

197

 

1’208

 

1’500

 

80.6%

 

 

Compensation earned during financial year as reported (A)

 

Less compensation earned from Jan to AGM of financial year (B)

 

Plus compensation accrued from Jan to AGM of year following financial year (C)

 

Total compensation earned for the period from AGM to AGM of medmix (A-B+C)

 

Amount approved by shareholders at respective AGM

 

Ratio between compensation earned for the period from AGM to AGM versus amount approved by shareholders

2022 AGM - 2023 AGM

 

2022

 

January 01, 2022 to 2022 AGM medmix

 

January 01, 2023 to 2023 AGM medmix

 

2022 AGM to 2023 AGM

 

2022 AGM

 

2022 AGM

Board of Directors Total

 

1’122

 

82

 

150

 

1’188

 

1’500

 

79.2%